Pricing Log in Create free account

Evolus, Inc. (EOLS) vs Evotec AG (EVO)

Evolus, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $630.4M against $448.8M — 1.4× the size. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 2.15%. Evolus, Inc. has the higher net margin (−9.56% vs −26.2%) and the lower return on invested capital (−12.6% vs 0.00%). Across the 17 metrics below, Evolus, Inc. leads on 10 and Evotec AG on 7.

Valuation

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.39 0.72 2.08
P/B n/m 0.81 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.98 0.74 2.87
Earnings yield (6.85%) (36.25%) (15.94%)
Free cash flow yield (1.94%) (32.04%) 0.00%

Profitability

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
Gross margin 66.38% 11.42% 53.51%
Operating margin (4.79%) (21.35%) 0.00%
Net margin (9.56%) (26.20%) (2.45%)
Free cash flow margin (2.71%) 0.00% 0.00%
Return on equity 93.47% 0.00% (0.80%)
Return on assets (12.38%) 0.00% (1.67%)
Return on invested capital (12.60%) 0.00% 0.00%

Growth

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 13.87% 2.15% 5.22%
EPS growth (last fiscal year) 1.23% 44.89% 42.91%
Revenue growth, 5-year CAGR 39.36% 9.28% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
Debt to equity (4.15) 0.72 0.04
Current ratio 1.42 2.33 2.41
Net debt to EBITDA (4.08) (0.64) 1.01

Dividend

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric EOLS EVO Drug Manufacturers Specialty & Generic median
Market cap 448.82m 630.44m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack